increasing number of reports of health problems from users, including skin and respiratory sensitisation and irritant effects. Whereas sensitisation does not seem to be common it is important because affected subjects may have to be transferred to work that does not involve a risk of exposure to glutaraldehyde.
Glutaraldehyde is widely used in hospitals as a cold sterilising and disinfecting solution, in particular for endoscopes and other delicate instruments that may be damaged by hypochlorite solution, the only other agent currently recommended for its effectiveness against HIV. It is also present as a hardening agent for emulsions in certain x ray developing solutions. Some glutaraldehyde is liberated when x ray films are developed.
The United Kingdom Health and Safety Executive's National Interest Group for the Health Service has identified glutaraldehyde as a substance that should be given particular consideration when making assessments under the Control of Substances Hazardous to Health (COSHH) Regulations 1988' within hospitals. The reason given for highlighting glutaraldehyde was a steadily increasing number of reports of health problems from users, including skin and respiratory sensitisation and irritant effects. Whereas sensitisation does not seem to be common it is important because affected subjects may have to be transferred to work that does not involve a risk of exposure to glutaraldehyde.
The objectives of the study reported in this paper were to assess personal exposures during the use of glutaraldehyde in cold sterilising and in x ray development processes and to provide advice on appropriate control measures.
Glutaraldehyde is a volatile substance and under certain circumstances significant airborne concentrations may be generated at room temperature. The vapours are irritating to the skin, eyes, nose, and lungs, an effect enhanced when the material is "activated" by the addition of sodium bicarbonate, as occurs, for example, with cold sterilising solutions. Corrado et al2 presented four case studies of endoscopy nurses complaining of respiratory symptoms due to glutaraldehyde, of which two had positive provocation tests. Norback3 surveyed the prevalence of skin and respiratory symptoms in hospital workers exposed to glutaraldehyde and compared these with a non-exposed control group. A significantly increased rate of skin and respiratory symptoms and headaches was found in the exposed group. For personnel using manual procedures the 15 minute time weighted average (TWA) exposures were in the range < 0-01-0-57 mg m-3. For personnel using automatic sterilisers the 15 minute TWA exposures were in the range 0-01-0-18 mg m-3. The results for a well ventilated room (range 0-01-0-03 mg m-3) were lower than those from a poorly ventilated room (range 0 13-018 mg m-3). It is of interest to note that in this study the symptoms that were most significantly associated with glutaraldehyde were skin related. Jachuk et al4 reported eight cases of discomfort including watering eyes, rhinitis, breathlessness, and dermatitis in endoscopy staff exposed to glutaraldehyde. Samples were collected in bubblers containing 3-methyl-2-benzothiazolinone hydrazone hydrochloride (MBTH) and it should be noted that the sampling procedure used will respond to any airborne aldehyde present during the survey commented spontaneously that they suffered from rhinitis, which they attributed to exposure to glutaraldehyde. This implies that some persons may experience adverse effects at concentrations below the current occupational exposure standard and indicates that a review of this limit may be appropriate. Glutaraldehyde solution was used in some locations for sterilising instruments that could have been treated by standard heat sterilisation. The reasons given for this included the fact that insufficient equipment was available to cover the requirements of particular clinics. We were also told during the survey that glutaraldehyde had been used to clean down bench surfaces in a haematology laboratory to "kill" HIV although this practice had been discontinued. In one hospital suction bottles used to receive excretions from patients contained, and were cleaned with glutaraldehyde. 
